Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
3,164,299
-
Share change
-
+2,827,591
-
Total reported value
-
$140,338,000
-
Price per share
-
$44.19
-
Number of holders
-
12
-
Value change
-
+$125,356,192
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q3 2016
As of 30 Sep 2016,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,164,299 shares.
The largest 10 holders included
WCM INVESTMENT MANAGEMENT/CA, THORNBURG INVESTMENT MANAGEMENT INC, PARAMETRIC PORTFOLIO ASSOCIATES LLC, Azimuth Capital Management LLC, Boston Common Asset Management, LLC, GARRISON BRADFORD & ASSOCIATES INC, EVERETT HARRIS & CO /CA/, Hemenway Trust Co LLC, GLENMEDE TRUST CO NA, and PRINCETON CAPITAL MANAGEMENT INC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.